TSX:BLU (Bellus Health)

About BLU

BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.
  • Bellus Health (TSX: BLU) Latest News

    Biotech stocks
    Coronavirus

    Is Bellus Health Stock Still a Buy After 30% Earnings Jump?

    The biotech continues to make progress on obtaining FDA approval for its chronic-cough therapy.

    Read more »

    TSX Today
    Metals and Mining Stocks

    TSX Today: What to Watch for in Stocks on Tuesday, December 14

    TSX stocks might open on a mixed note Tuesday following a choppy movement in the commodities market early this morning.

    Read more »

    healthcare pharma
    Coronavirus

    Why BELLUS Health Exploded 60% on Monday

    BELLUS Health (TSX:BLU)(NASDAQ:BLU) shares soared after positive results from its recent trial for the treatment of chronic cough.

    Read more »

    healthcare pharma
    Investing

    The 50% Healthcare Index Dip and a Silver Lining

    The individual elements/companies within the healthcare sectors move in less harmony than most other sectors, but a huge sector-wide discount…

    Read more »

    healthcare pharma
    Stocks for Beginners

    2 Canadian Healthcare Stocks That Are All-Stars in the Making

    These two top Canadian healthcare stocks are both analyst favourites and offer some of the best growth potential of any…

    Read more »

    stocks rising
    Stocks for Beginners

    4 Canadian Stocks That Could Soar 68% or More According to Bay Street

    If you're looking for Canadian growth stocks to buy, these four Canadian companies are some of the best opportunities on…

    Read more »

    healthcare pharma
    Investing

    Why BELLUS Health (TSX:BLU) Stock Jumped 30% on the TSX Today!

    BELLUS (TSX:BLU)(NASDAQ:BLU) stock went stratospheric with the promise of a new drug that could boost fourth-quarter revenue.

    Read more »

    edit Sale sign, value, discount
    Energy Stocks

    3 Bargain TSX Stocks to Buy While They’re Low

    Bargain deals are plenty, even if the TSX’s rally continues in July 2021. Buy shares of Canacol Energy stock, Fire…

    Read more »

    Growth from coins
    Cannabis Stocks

    3 Top Growth Stocks to Own Before They Take Off

    Growth investors should be eyeing the WELL Health Technologies stock, Fire & Flower stock, and BELLUS Health stock. If you…

    Read more »

    Dice engraved with the words buy and sell
    Dividend Stocks

    Got $2,000? 4 Top Stocks to Buy This Month

    Canadians with only $2,000 in capital can create a diversified portfolio that could deliver substantial gains. The top but affordable…

    Read more »

    stock data
    Investing

    TFSA Investors: This Pharma Stock Could Rise Significantly

    Bellus Health Inc. (TSX:BLU)(NASDAQ:BLU) is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough.

    Read more »

    Woman has an idea
    Cannabis Stocks

    2 TSX Stocks That Could Return 100% in 2021

    Two Canadian firms will benefit from the rapidly evolving health and wellness industry. The Bellus Health stock and Neptune Wellness…

    Read more »